Wordt geladen...
Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?
5-fluorouracil (5-FU) and its prodrug capecitabine are frequently prescribed in oncology. While usually well tolerated, toxicity can be severe, and even life-threatening. A dihydropyrimidine dehydrogenase (DPD) deficiency can cause severe toxicity. Current testing for DPD deficiency does not meet th...
Bewaard in:
| Gepubliceerd in: | J Adv Pract Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Harborside Press LLC
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7517765/ https://ncbi.nlm.nih.gov/pubmed/33542850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.1.4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|